Patents by Inventor Joseph Ferraro

Joseph Ferraro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9801913
    Abstract: A barrier layer and corresponding method of making provide anti-inflammatory, non-inflammatory, and anti-adhesion functionality for a medical device implantable in a patient. The barrier layer can be combined with a medical device structure to provide anti-adhesion characteristics, in addition to improved healing, non-inflammatory, and anti-inflammatory response. The barrier layer is generally formed of a naturally occurring oil, or an oil composition formed in part of a naturally occurring oil, that is at least partially cured forming a cross-linked gel. In addition, the oil composition can include a therapeutic agent component, such as a drug or other bioactive agent.
    Type: Grant
    Filed: September 28, 2005
    Date of Patent: October 31, 2017
    Assignee: ATRIUM MEDICAL CORPORATION
    Inventors: Joseph Ferraro, Lisa Rogers, Paul Martakos, Theodore Karwoski, Steve A. Herweck, Keith Faucher, Philip McNamara
  • Patent number: 9592324
    Abstract: A barrier layer device is formed of an underlying biocompatible structure having a barrier layer coating that can exhibit anti-inflammatory properties, non-inflammatory properties, and/or adhesion-limiting properties, as well as generate a modulated healing effect on injured tissue. As implemented herein, the barrier layer is a non-polymeric cross-linked gel derived at least in part from a fatty acid compound, and may include a therapeutic agent. The underlying structure can be in the form of a surgical mesh. The barrier device is further provided with reinforced sections or portions to aid with the fastening of the barrier device for implantation purposes and prohibits or substantially reduces the occurrence of excessive stretching and tearing. The barrier device is implantable in a patient for short term or long term applications, and can include controlled release of the therapeutic agent.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: March 14, 2017
    Assignee: ATRIUM MEDICAL CORPORATION
    Inventors: Steve A. Herweck, Joseph Ferraro, Paul Martakos, Theodore Karwoski, Anthony Richard Horton
  • Patent number: 9492596
    Abstract: A barrier layer device is formed of an underlying biocompatible structure having a barrier layer coating that can exhibit anti-inflammatory properties, non-inflammatory properties, and/or adhesion-limiting properties, as well as generate a modulated healing effect on injured tissue. As implemented herein, the barrier layer is a non-polymeric cross-linked gel derived at least in part from a fatty acid compound, and may include a therapeutic agent. The underlying structure can be in the form of a surgical mesh. The barrier device is further provided with anchoring reinforcements to aid with the fastening of the barrier device for implantation purposes and reinforcing truss sections or portions that prohibit or substantially reduce the occurrence of excessive stretching and tearing. The barrier device is implantable in a patient for short term or long term applications, and can include controlled release of the therapeutic agent.
    Type: Grant
    Filed: February 2, 2007
    Date of Patent: November 15, 2016
    Assignee: ATRIUM MEDICAL CORPORATION
    Inventors: Steve A. Herweck, Joseph Ferraro, Paul Martakos, Theodore Karwoski, Anthony Richard Horton
  • Publication number: 20160324816
    Abstract: The present invention is directed toward fatty acid-based particles, and methods of making such particles. The particles can be associated with an additional, therapeutic agent. Also provided herein is a method of forming fatty acid particles, comprising associating a cross-linked, fatty acid-derived biomaterial with a cryogenic liquid; and fragmenting the bio material/cryogenic liquid composition, such that fatty acid particles are formed. The particles can be used for a variety of therapeutic applications.
    Type: Application
    Filed: July 22, 2016
    Publication date: November 10, 2016
    Applicant: ATRIUM MEDICAL CORPORATION
    Inventors: Thomas M. SWANICK, Joseph FERRARO, Lisa ROGERS, Paul MARTAKOS
  • Patent number: 9427423
    Abstract: The present invention is directed toward fatty acid-based particles, and methods of making such particles. The particles can be associated with an additional, therapeutic agent. Also provided herein is a method of forming fatty acid particles, comprising associating a cross-linked, fatty acid-derived biomaterial with a cryogenic liquid; and fragmenting the bio material/cryogenic liquid composition, such that fatty acid particles are formed. The particles can be used for a variety of therapeutic applications.
    Type: Grant
    Filed: March 10, 2009
    Date of Patent: August 30, 2016
    Assignee: ATRIUM MEDICAL CORPORATION
    Inventors: Thomas M. Swanick, Joseph Ferraro, Lisa Rogers, Paul Martakos
  • Publication number: 20160206789
    Abstract: Exemplary embodiments of the present invention provide adhesion barriers having anti-adhesion and tissue fixating properties. The adhesion barriers are formed of fatty acid based films. The fatty acid-based films may be formed from fatty acid-derived biomaterials. The films may be coated with, or may include, tissue fixating materials to create the adhesion barrier. The adhesion barriers are well tolerated by the body, have anti-inflammation properties, fixate, well to tissue, and have a residence time sufficient to prevent post-surgical adhesions.
    Type: Application
    Filed: January 20, 2016
    Publication date: July 21, 2016
    Applicant: ATRIUM MEDICAL CORPORATION
    Inventors: Thomas M. Swanick, Joe Bienkiewicz, Joseph Ferraro, Paul Martakos, Keith M. Faucher, Alicia Dale
  • Patent number: 9278161
    Abstract: Exemplary embodiments of the present invention provide adhesion barriers having anti-adhesion and tissue fixating properties. The adhesion barriers are formed of fatty acid based films. The fatty acid-based films may be formed from fatty acid-derived biomaterials. The films may be coated with, or may include, tissue fixating materials to create the adhesion barrier. The adhesion barriers are well tolerated by the body, have anti-inflammation properties, fixate, well to tissue, and have a residence time sufficient to prevent post-surgical adhesions.
    Type: Grant
    Filed: October 19, 2009
    Date of Patent: March 8, 2016
    Assignee: Atrium Medical Corporation
    Inventors: Thomas M. Swanick, Joe Bienkiewicz, Joseph Ferraro, Paul Martakos, Keith M. Faucher, Alicia Dale
  • Patent number: 9220820
    Abstract: Coatings for medical devices, methods of making the coatings, and methods of using them are described.
    Type: Grant
    Filed: July 16, 2013
    Date of Patent: December 29, 2015
    Inventors: Keith M. Faucher, Hui Tang, Lisa Rogers, Joseph Ferraro, Paul Martakos, Steven A. Herweck, Theodore Karwoski
  • Publication number: 20150224233
    Abstract: Fatty acid-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.
    Type: Application
    Filed: April 20, 2015
    Publication date: August 13, 2015
    Applicant: ATRIUM MEDICAL CORPORATION
    Inventors: Keith M. FAUCHER, Hui TANG, Joseph FERRARO, Paul MARTAKOS, Steve A. HERWECK, Theodore KARWOSKI, Scott E. CORBEIL
  • Patent number: 9012506
    Abstract: Fatty acid-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.
    Type: Grant
    Filed: December 1, 2008
    Date of Patent: April 21, 2015
    Assignee: Atrium Medical Corporation
    Inventors: Keith M. Faucher, Hui Tang, Joseph Ferraro, Paul Martakos, Steve A. Herweck, Theodore Karwoski, Scott E. Corbeil
  • Publication number: 20150079191
    Abstract: A cured non-polymeric gel including a plurality of non-polymeric cross-links. The non-polymeric cross-links result from curing an oil or oil composition at selected curing conditions to achieve a desired amount of cross-linking to form the non-polymeric get. The desired amount of cross-linking is selected based on a desired rate of degradation of the gel after the gel is implanted. The oil or oil composition comprises one or more of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), or alphalinolenic acid (ALA).
    Type: Application
    Filed: October 10, 2014
    Publication date: March 19, 2015
    Applicant: ATRIUM MEDICAL CORPORATION
    Inventors: Roger LABRECQUE, Philip MCNAMARA, Joseph FERRARO, Lisa ROGERS, Paul MARTAKOS, Theodore KARWOSKI, Steve A. HERWECK, Keith M. FAUCHER, Thomas M. SWANICK
  • Patent number: 8962023
    Abstract: A method of UV curing and corresponding resulting non-polymeric cross-linked gel are provided. The cross-linked gel can be combined with a medical device structure. The cross-linked gel can provide anti-adhesion characteristics, in addition to improved healing and anti-inflammatory response. The cross-linked gel is generally formed of a naturally occurring oil, or an oil composition formed in part of a naturally occurring oil, that is at least partially cured forming a cross-linked gel derived from at least one fatty acid compound. In addition, the oil composition can include a therapeutic agent component, such as a drug or other bioactive agent. The curing method can vary the application of UV light in both intensity and duration to achieve a desired amount of cross-linking forming the gel.
    Type: Grant
    Filed: September 28, 2005
    Date of Patent: February 24, 2015
    Assignee: Atrium Medical Corporation
    Inventors: Roger Labrecque, Philip McNamara, Joseph Ferraro, Lisa Rogers, Paul Martakos, Theodore Karwoski, Steve A. Herweck, Keith Faucher, Thomas M. Swanick
  • Patent number: 8858978
    Abstract: A method of curing and corresponding resulting non-polymeric cross-linked gel are provided. The cross-linked gel can be combined with a medical device structure. The cross-linked gel can provide anti-adhesion characteristics, in addition to improved healing and anti-inflammatory response. The cross-linked gel is generally formed of a naturally occurring oil, or an oil composition formed in part of a naturally occurring oil, that is at least partially cured forming a cross-linked gel derived from at least one fatty acid compound. In addition, the oil composition can include a therapeutic agent component, such as a drug or other bioactive agent. The curing method can vary the application of heat in both temperature and duration to achieve a desired amount of cross-linking forming the gel.
    Type: Grant
    Filed: September 28, 2005
    Date of Patent: October 14, 2014
    Assignee: Atrium Medical Corporation
    Inventors: Roger Labrecque, Philip McNamara, Joseph Ferraro, Lisa Rogers, Paul Martakos, Theodore Karwoski, Steve A. Herweck, Keith M. Faucher, Thomas M. Swanick
  • Patent number: 8844406
    Abstract: A seal breaker to break the seal of a container includes the container cap having either one or more slots with an adjacent rigid portion capable of penetrating the seal or one or more pointed projections capable of penetrating the seal or one or more pointed projections.
    Type: Grant
    Filed: December 30, 2013
    Date of Patent: September 30, 2014
    Inventor: Joseph Ferraro
  • Patent number: 8795703
    Abstract: A stand-alone film is derived at least in part from fatty acids. The stand-alone film can have anti-adhesive, anti-inflammatory, non-inflammatory, and wound healing properties, and can additionally include one or more therapeutic agents incorporated therein. Corresponding methods of making the stand-alone film include molding, casting, or otherwise applying a liquid or gel to a substrate, and curing or otherwise treating to form the stand-alone film. The resulting stand-alone film is bioabsorbable.
    Type: Grant
    Filed: September 28, 2005
    Date of Patent: August 5, 2014
    Assignee: Atrium Medical Corporation
    Inventors: Thomas M. Swanick, Joseph Ferraro, Paul Martakos, Lisa Rogers, Theodore Karwoski, Steve A. Herweck, Keith Faucher, Philip McNamara
  • Patent number: 8722077
    Abstract: A coated medical device and a method of providing a coating on an implantable medical device result in a medical device having a bio-absorbable coating. The coating includes a bio-absorbable carrier component. In addition to the bio-absorbable carrier component, a therapeutic agent component can also be provided. The coated medical device is implantable in a patient to effect controlled delivery of the coating, including the therapeutic agent, to the patient.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: May 13, 2014
    Assignee: Atrium Medical Corporation
    Inventors: Roger Labrecque, Geoffrey Moodie, Joseph Ferraro, Lisa Rogers, Paul Martakos, Theodore Karwoski, Steve A. Herweck
  • Patent number: 8722132
    Abstract: Methods and devices for the provision of a coating on an implantable medical device. The coating includes a bio-absorbable carrier component. In addition to the bio-absorbable carrier component, a therapeutic agent component can also be provided. The methods and devices provide a coating having improved uniformity and coverage which in turn allow for greater control of the amount and dosage of the coating.
    Type: Grant
    Filed: July 18, 2011
    Date of Patent: May 13, 2014
    Assignee: Atrium Medical Corporation
    Inventors: Roger Labrecque, Geoffrey Moodie, Joseph Ferraro, Lisa Rogers, Paul Martakos, Theodore Karwoski, Steve A. Herweck, Suzanne Conroy, Brian Sunter, Georgette Henrich
  • Publication number: 20140110407
    Abstract: A seal breaker to break the seal of a container includes the container cap having either one or more slots with an adjacent rigid portion capable of penetrating the seal or one or more pointed projections capable of penetrating the seal or one or more pointed projections.
    Type: Application
    Filed: December 30, 2013
    Publication date: April 24, 2014
    Inventor: Joseph Ferraro
  • Publication number: 20140010949
    Abstract: Coatings for medical devices, methods of making the coatings, and methods of using them are described.
    Type: Application
    Filed: July 16, 2013
    Publication date: January 9, 2014
    Inventors: Keith M. Faucher, Hui Tang, Lisa Rogers, Joseph Ferraro, Paul Martakos, Steven A. Herweck, Theodore Karwoski
  • Patent number: 8616090
    Abstract: A seal breaker to break the seal of a container includes the container cap having either one or more slots with an adjacent rigid portion capable of penetrating the seal or one or more pointed projections capable of penetrating the seal or one or more pointed projections.
    Type: Grant
    Filed: November 29, 2010
    Date of Patent: December 31, 2013
    Inventor: Joseph Ferraro